Newark, DE, October 17, 2005 --(PR.com
)-- TimTec Inc. is expressing customer and business partner appreciation as the company marks 10-years anniversary on the market of early drug-discovery.
Ten years in business, TimTec has matured into an internationally recognized expert in comprising diversity and targeted library collections tailored to fit drug discovery trends. Presently the company features its premier libraries: grand in diversity screening collection ActiMol-25K, 50K, or 70K
; drug-like and diverse in chemotypes ActiProbe-10K; attractive in price and value ScreenStart-5K; Natural Product Library of pure compounds and plant extract; and targeted libraries
(Kinase Modulators, GPCR Ligands, Anti-infectives, Potassium Channel Modulators, and Protease Inhibitors).
TimTec maintains extensive network of partners and suppliers worldwide to ensure the delivery of best products and services to its customers. MyriaScreen Diversity Collection of compounds with distinct drug-like properties is the successful result of the collaboration with Sigma-Aldrich Corporation.
TimTec , Inc. evolved from a venture started by the Zelinsky Institute of Organic Chemistry (ZIOC) in Russia in the late 1980’s. Tremendous growth opportunities in the bio-based industry prompted the management to establish operations in U.S. and expand further servicing customers world-wide. In 1995 the company incorporated in DE. During this timeframe the company had grown its product lines to include organic and synthetic compounds for HTS, building blocks, natural products, biotinylation reagents, specialty chemicals, chromatography columns, packing material, and chemical database management software. TimTec offers custom synthesis, quality control, and full service compound management services. TimTec goes on servicing bio-based industry research always remaining flexible to accommodate custom needs and requirements.
For more information about company products and services please visit:http://www.timtec.net